Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

Abuse Potential

6 clinical trials

21 products

Clinical trial
A Randomized, Double Blind, Active and Placebo Controlled, 5 Way Crossover Study to Determine the Abuse Potential of Orally Administered Gabapentin Enacarbil Immediate Release Capsules in Healthy, Nondependent Recreational Drug Users With Sedative Experience
Status: Completed, Estimated PCD: 2022-06-30
Product
Gabapentin Enacarbil Immediate Release
Product
Placebo
Product
Alprazolam
Product
Gabapentin Enacarbil
Clinical trial
A Randomized, Double-blind, Active- and Placebo-controlled, 6-way Crossover Study to Evaluate the Abuse Potential of Orally Administered Gabapentin Enacarbil Immediate Release Capsules Taken Alone and in Combination With Oxycodone in Healthy, Nondependent, Recreational Opioid Users
Status: Completed, Estimated PCD: 2023-04-25
Product
GE-IR
Product
Oxycodone
Product
GE-IR 200 mg + Oxycodone 20 mg
Product
GE-IR 450 mg + Oxycodone 20 mg
Product
GE-IR + Oxycodone
Product
Suvorexant
Clinical trial
A Single-Dose, Double-Blind, Placebo-Controlled, Randomized, Crossover Study to Determine the Abuse Potential of Single Oral Dose of Seltorexant Compared To Suvorexant and Zolpidem
Status: Completed, Estimated PCD: 2023-05-12
Product
Zolpidem
Product
Seltorexant
Product
Gabapentin
Clinical trial
A Phase 4 Randomized Double-blind Double-dummy Placebo & Active-controlled Single-dose Six-way Crossover Study Evaluating Abuse Potential of NEURONTIN® Taken Orally With Oxycodone HCL in Healthy Non-drug Dependent Recreational Opioid Users
Status: Completed, Estimated PCD: 2021-12-31
Product
Gabapentin + Oxycodone
Product
Gabapentin + Oxycodone HCl
Product
Oxycodone HCl
Product
placebo
Clinical trial
A Phase 4 Randomized Double-Blind Double-Dummy Placebo & Active-Controlled Single-Dose Six-Way Crossover Study Evaluating the Abuse Potential of Lyrica® Taken Orally With Oxycodone HCL in Healthy Non-Drug Dependent Recreational Opioid Users
Status: Completed, Estimated PCD: 2022-04-01
Product
Pregabalin
Product
Pregabalin with Oxycodone
Product
Pregabalin 450 mg + Oxycodone 20 mg
Clinical trial
A Phase 4, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Single-dose, Five-way Crossover Study Evaluating the Abuse Potential of Three Doses of NEURONTIN® Taken Orally in Healthy, Non-drug Dependent Participants With Sedative Drug Abuse Experience
Status: Completed, Estimated PCD: 2022-11-10
Product
Diazepam